Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response

NATerminatedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 12, 2017

Primary Completion Date

October 14, 2020

Study Completion Date

March 12, 2021

Conditions
Lymphoma, T-CellLymphoma, Large B-Cell, DiffuseLymphoma, Hodgkin
Interventions
DEVICE

MOOVCARE

web-mediated follow up

Trial Locations (15)

14000

Polyclinique du Parc, Caen

14033

Institut d'Hématologie de Basse Normandie, Caen

21000

Centre Hospitalier Univeritaire, Dijon

25030

Centre Hospitalier Universitaire Jean Minjoz, Besançon

33076

Institut Bergonié, Bordeaux

33077

Polyclinique Bordeaux Nord, Bordeaux

37044

Centre Hospitalier Universitaire, Tours

38700

CHU Grenoble, Grenoble

40000

Ch Mont de Marsan, Mont-de-Marsan

44277

Hôpital Privé du Confluent, Nantes

54000

Centre d'Oncologie de Gentilly, Nancy

56017

CHBA Vannes, Vannes

67000

Clinique Saint Anne, Strasbourg

72000

Centre Jean Bernard, Le Mans

75475

Hopital Saint Louis, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sivan Innovation Ltd.

INDUSTRY

collaborator

Takeda

INDUSTRY

lead

Weprom

OTHER